| Mitochondria dysfunction and impaired response to oxidative stress promotes proteostasis disruption in aged human cells D Trigo, A Nadais, A Carvalho, B Morgado, F Santos, S Nóbrega-Pereira, ... Mitochondrion 69, 1-9, 2023 | 16 | 2023 |
| Development of a library of thiophene‐based drug‐like Lego molecules: Evaluation of their anion binding, transport properties, and cytotoxicity P Vieira, MQ Miranda, I Marques, S Carvalho, LJ Chen, ENW Howe, ... Chemistry–A European Journal 26 (4), 888-899, 2020 | 12 | 2020 |
| Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40? HW Klafki, B Morgado, O Wirths, O Jahn, C Bauer, H Esselmann, ... Fluids and Barriers of the CNS 19 (1), 96, 2022 | 8 | 2022 |
| Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease B Morgado, HW Klafki, C Bauer, K Waniek, H Esselmann, O Wirths, ... European Archives of Psychiatry and Clinical Neuroscience, 1-13, 2024 | 1 | 2024 |
| Oligodendrocytes and neurons contribute to amyloid-β deposition in Alzheimer's disease AO Sasmita, C Depp, T Nazarenko, T Sun, SB Siems, X Yu, C Boehler, ... bioRxiv, 2023.12. 11.570514, 2023 | 1 | 2023 |
| Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease J Vogelgsang, N Hansen, M Stark, M Wagner, H Klafki, BM Morgado, ... Alzheimer's & Dementia, 2024 | | 2024 |
| Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains O Wirths, C Lehnen, M Fricke, I Talucci, HW Klafki, B Morgado, ... Neuropathology and Applied Neurobiology 50 (3), e12991, 2024 | | 2024 |
| Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40 HW Klafki, O Wirths, O Jahn, B Morgado, H Esselmann, J Wiltfang Clinical Chemistry and Laboratory Medicine (CCLM) 62 (2), e56-e57, 2024 | | 2024 |
| The association of body mass index and body composition with plasma amyloid beta levels M Hermesdorf, H Esselmann, B Morgado, A Jahn-Brodmann, ... Brain Communications 5 (5), fcad263, 2023 | | 2023 |
| Prognostic value of plasma Amyloid‐β 42/40 ratio in early and pre‐clinical AD J Vogelgsang, H Klafki, B Morgado, A Jahn‐Brodmann, H Esselmann, ... Alzheimer's & Dementia 18, e063242, 2022 | | 2022 |
